We have the Wonder Drug IHL-675A to back up any hiccups from IHL-42X
Just last week for a whopping $7.1 BLN
Roche to gain gut disease drug in $7.1B deal for Roivant subsidiary
The Swiss pharmaceutical company has agreed to buy Telavant, a company set up by Roivant and Pfizer to develop a promisinginflammatory bowel disease treatment
https://www.biopharmadive.com/news/roivant-roche-pfizer-tl1a-telavant-acquire-ibd-drug/687882/That's the beauty of having so many pipelines.
I hope we keep IHL-675A it's got so much more potential than IHL-42X
GLAH
